Agape ATP Corp — fact timeline

Agape ATP Corp received a nasdaq delisting notice notice regarding other (rules 5810(c)(3)(A)(iii)).

“February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to delist the Company’s securities. The Staff’s determination was based on that as of January 30, 2026, the Company’s securities had a closing bid of $0.10 or less for the last ten consecutive trading days, and accordingly, is subject to the provisions under Listing Rule 5810(c)(3)(A)(iii), the “Low Priced Stocks” Rule. On March 10, 2026, the Company received a letter from the Hearings Advisor of Nasdaq, noting that the Nasdaq Listing Qualifications staff have advised th”

Agape ATP Corp received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 27, 2026, notifying the Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis for delisting the Company’s securities from Nasdaq. On February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del”

Agape ATP Corp entered into Collaboration Agreement with Citadel Investment LLC (effective 2026-03-06).

“On March 6, 2026, Agape ATP Corporation (the “Company”) through its subsidiary ATPC Green Energy Sdn. Bhd. (“ATPC Green Energy”), entered into a non-exclusive collaboration agreement (“Collaboration Agreement”) with Citadel Investment LLC”

Agape ATP Corp: Approved amendment to Articles of Incorporation to effect reverse stock splits up to 1-for-5000, with a specific 1-for-50 reverse stock split to be effected on February 9, 2026 (effective 2026-02-09).

“the Company’s stockholders approved an amendment to the Company’s Articles of Incorporation to effect one or more reverse stock splits of the company’s issued and outstanding Common Stock at any time before the next annual meeting of stockholders of the Company, in aggregate, of up to one-for-five thousand (1:5000), with the timing of any reverse split to be determined by the board in its discretion.”

Agape ATP Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to delist the Company’s securities. The Staff’s determination was based on that as of January 30, 2026, the Company’s securities had a closing bid of $0.10 or less for the last ten consecutive trading days, and accordingly, is subject to the provisions under Listing Rule 5810(c)(3)(A)(iii), the “Low Priced Stocks” Rule. The Company has the opportunity to request a hearing with the Hearings Panel (the “Panel”), by February 9, 2026. The Company intends to make the request”

Agape ATP Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 27, 2026, notifying the Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis for delisting the Company’s securities from Nasdaq. On February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del”

Agape ATP Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 27, 2026, Agape ATP Corporation (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from December 10, 2025 to January 26, 2026, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Nasdaq has provided the Company with an 180 calendar days compliance period, or until July 27, 2026, in which to regain compliance with Nasdaq continued listi”

Rose Marie Kadende Kaiser was appointed as independent director at Agape ATP Corp.

“On November 15, 2024, Ms. Rose Marie Kadende Kaiser, PhD (“Ms. Rose, PhD) was appointed as an independent director of the Board to fill the vacancy left by Dr Vong, PhD’s resignation.”

Vong John Hing was appointed as Deputy Chairman of the Board at Agape ATP Corp.

“Dr. Vong, PhD will serve as the Deputy Chairman of the Board following his resignation effective on the same day.”

Ni Luh Dharma Kerti Natih was appointed as independent director at Agape ATP Corp.

“On October 1, 2024, Dr. Ni Luh Dharma Kerti Natih (Dr. Natih) was appointed as an independent director of the Board to fill the vacancy left by Mr. Chee’s resignation.”

Chee Chin Aik resigned as independent director at Agape ATP Corp.

“On October 1, 2024, Mr. Chee Chin Aik (“Mr. Chee”) resigned as our independent director of the Board of Directors (the “Board”), the chairman of the nominating and governance committee and as a member of the audit and compensation committees of the Agape ATP Corporation (the “Company”), effective from October 1, 2024.”

Agape ATP Corp engaged Assentsure PAC as its auditor.

“We have engaged Assentsure PAC (“Assentsure”) as our independent registered public accounting firm, effective April 29, 2024.”

Agape ATP Corp dismissed Marcum Asia CPAs LLP as its auditor.

“On April 24, 2024, our board of directors resolved to dismiss Marcum Asia CPAs LLP (“Marcum Asia”) as our independent accountants.”